Trade Tabula Rasa HealthCare - TRHC CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Tabula Rasa HealthCare Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 10.38 |
Open* | 10.4 |
1-Year Change* | 170.83% |
Day's Range* | 10.39 - 10.46 |
52 wk Range | 3.15-10.43 |
Average Volume (10 days) | 152.06K |
Average Volume (3 months) | 8.76M |
Market Cap | 281.37M |
P/E Ratio | -100.00K |
Shares Outstanding | 27.05M |
Revenue | 338.12M |
EPS | -2.46 |
Dividend (Yield %) | N/A |
Beta | 1.58 |
Next Earnings Date | Nov 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 2, 2023 | 10.46 | 0.07 | 0.67% | 10.39 | 10.46 | 10.39 |
Nov 1, 2023 | 10.38 | -0.01 | -0.10% | 10.39 | 10.40 | 10.38 |
Oct 31, 2023 | 10.39 | 0.01 | 0.10% | 10.38 | 10.40 | 10.38 |
Oct 30, 2023 | 10.38 | 0.02 | 0.19% | 10.36 | 10.39 | 10.36 |
Oct 27, 2023 | 10.35 | 0.00 | 0.00% | 10.35 | 10.36 | 10.35 |
Oct 26, 2023 | 10.35 | -0.01 | -0.10% | 10.36 | 10.36 | 10.35 |
Oct 25, 2023 | 10.35 | -0.01 | -0.10% | 10.36 | 10.36 | 10.35 |
Oct 24, 2023 | 10.36 | 0.00 | 0.00% | 10.36 | 10.37 | 10.36 |
Oct 23, 2023 | 10.35 | -0.02 | -0.19% | 10.37 | 10.37 | 10.35 |
Oct 20, 2023 | 10.35 | -0.02 | -0.19% | 10.37 | 10.37 | 10.35 |
Oct 19, 2023 | 10.36 | 0.00 | 0.00% | 10.36 | 10.36 | 10.36 |
Oct 18, 2023 | 10.36 | -0.01 | -0.10% | 10.37 | 10.37 | 10.36 |
Oct 17, 2023 | 10.36 | 0.00 | 0.00% | 10.36 | 10.36 | 10.36 |
Oct 16, 2023 | 10.36 | 0.00 | 0.00% | 10.36 | 10.37 | 10.36 |
Oct 13, 2023 | 10.37 | -0.01 | -0.10% | 10.38 | 10.39 | 10.37 |
Oct 12, 2023 | 10.37 | -0.01 | -0.10% | 10.38 | 10.38 | 10.37 |
Oct 11, 2023 | 10.37 | 0.01 | 0.10% | 10.36 | 10.37 | 10.35 |
Oct 10, 2023 | 10.35 | -0.01 | -0.10% | 10.36 | 10.36 | 10.35 |
Oct 9, 2023 | 10.36 | 0.00 | 0.00% | 10.36 | 10.36 | 10.35 |
Oct 6, 2023 | 10.36 | 0.01 | 0.10% | 10.35 | 10.36 | 10.34 |
Tabula Rasa HealthCare Events
Time (UTC) | Country | Event |
---|---|---|
Monday, March 4, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Tabula Rasa HealthCare Inc Earnings Release Q4 2023 Tabula Rasa HealthCare Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 299.516 | 259.882 | 221.389 | 284.707 | 204.27 |
Revenue | 299.516 | 259.882 | 221.389 | 284.707 | 204.27 |
Cost of Revenue, Total | 232.603 | 193.378 | 160.618 | 181.355 | 137.669 |
Gross Profit | 66.913 | 66.504 | 60.771 | 103.352 | 66.601 |
Total Operating Expense | 368.491 | 302.623 | 262.566 | 317.356 | 254.009 |
Selling/General/Admin. Expenses, Total | 85.465 | 74.134 | 63.236 | 76.17 | 37.848 |
Research & Development | 14.483 | 14.629 | 14.426 | 21.739 | 12.222 |
Depreciation / Amortization | 23.347 | 20.482 | 16.633 | 34.276 | 16.802 |
Unusual Expense (Income) | 8.943 | 0 | 7.653 | 3.816 | 49.468 |
Operating Income | -68.975 | -42.741 | -41.177 | -32.649 | -49.739 |
Interest Income (Expense), Net Non-Operating | -9.034 | -9.107 | -20.743 | -15.986 | -0.906 |
Other, Net | 1.064 | 0 | 0 | ||
Net Income Before Taxes | -76.945 | -51.848 | -61.92 | -48.635 | -50.645 |
Net Income After Taxes | -77.334 | -52.238 | -56.511 | -32.436 | -47.269 |
Net Income Before Extra. Items | -77.334 | -52.238 | -56.511 | -32.436 | -47.269 |
Net Income | -147.51 | -79.055 | -80.966 | -32.436 | -47.269 |
Total Adjustments to Net Income | 0 | ||||
Income Available to Common Excl. Extra. Items | -77.334 | -52.238 | -56.511 | -32.436 | -47.269 |
Income Available to Common Incl. Extra. Items | -147.51 | -79.055 | -80.966 | -32.436 | -47.269 |
Diluted Net Income | -147.51 | -79.055 | -80.966 | -32.436 | -47.269 |
Diluted Weighted Average Shares | 24.2935 | 23.2907 | 21.8154 | 20.6223 | 19.0983 |
Diluted EPS Excluding Extraordinary Items | -3.18332 | -2.24287 | -2.59042 | -1.57286 | -2.47504 |
Diluted Normalized EPS | -2.78428 | -2.18245 | -2.31365 | -1.28869 | -0.79142 |
Total Extraordinary Items | -70.176 | -26.817 | -24.455 | ||
Other Operating Expenses, Total | 3.65 | 0 | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 90.036 | 88.277 | 82.708 | 77.101 | 72.597 |
Revenue | 90.036 | 88.277 | 82.708 | 77.101 | 72.597 |
Cost of Revenue, Total | 67.507 | 67.524 | 63.016 | 60.235 | 56.631 |
Gross Profit | 22.529 | 20.753 | 19.692 | 16.866 | 15.966 |
Total Operating Expense | 99.068 | 94.433 | 100.039 | 100.75 | 82.685 |
Selling/General/Admin. Expenses, Total | 20.331 | 19.03 | 18.842 | 30.774 | 17.322 |
Research & Development | 1.777 | 1.279 | 3.257 | 4.018 | 3.243 |
Depreciation / Amortization | 6.103 | 6.2 | 6.393 | 5.723 | 5.49 |
Unusual Expense (Income) | 0 | 0 | 4.881 | 0 | 0 |
Operating Income | -9.032 | -6.156 | -17.331 | -23.649 | -10.088 |
Interest Income (Expense), Net Non-Operating | -1.144 | -1.265 | -1.604 | -2.717 | -2.444 |
Net Income Before Taxes | -9.61 | -6.969 | -18.35 | -25.887 | -12.532 |
Net Income After Taxes | -9.743 | -7.074 | -18.371 | -25.88 | -12.691 |
Net Income Before Extra. Items | -9.743 | -7.074 | -18.371 | -25.88 | -12.691 |
Total Extraordinary Items | -0.108 | -8.824 | -11.271 | -14.185 | -36.919 |
Net Income | -9.851 | -15.898 | -29.642 | -40.065 | -49.61 |
Income Available to Common Excl. Extra. Items | -9.743 | -7.074 | -18.371 | -25.88 | -12.691 |
Income Available to Common Incl. Extra. Items | -9.851 | -15.898 | -29.642 | -40.065 | -49.61 |
Diluted Net Income | -9.851 | -15.898 | -29.642 | -40.065 | -49.61 |
Diluted Weighted Average Shares | 25.422 | 25.2447 | 24.9469 | 24.3502 | 23.9597 |
Diluted EPS Excluding Extraordinary Items | -0.38325 | -0.28022 | -0.7364 | -1.06283 | -0.52968 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.38325 | -0.28022 | -0.55983 | -1.03135 | -0.49132 |
Other Operating Expenses, Total | 3.35 | 0.4 | 3.65 | -0.001 | |
Other, Net | 0.566 | 0.452 | 0.585 | 0.479 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 170.26 | 89.895 | 93.212 | 94.538 | 63.311 |
Cash and Short Term Investments | 70.017 | 9.668 | 23.362 | 42.478 | 20.278 |
Cash | 70.017 | 9.668 | 23.362 | 42.478 | 20.278 |
Total Receivables, Net | 50.744 | 58.177 | 54.529 | 35.288 | 27.95 |
Accounts Receivable - Trade, Net | 34.367 | 46.92 | 40.117 | 35.288 | 27.95 |
Total Inventory | 6.566 | 5.444 | 4.261 | 3.7 | 3.594 |
Prepaid Expenses | 4.664 | 4.993 | 3.739 | 4.299 | 2.573 |
Other Current Assets, Total | 38.269 | 11.613 | 7.321 | 8.773 | 8.916 |
Total Assets | 384.149 | 499.418 | 514.44 | 492.391 | 270.957 |
Property/Plant/Equipment, Total - Net | 19.641 | 34.728 | 36.781 | 37.898 | 11.865 |
Property/Plant/Equipment, Total - Gross | 38.665 | 56.595 | 54.703 | 51.626 | 21.228 |
Accumulated Depreciation, Total | -19.024 | -21.867 | -17.922 | -13.728 | -9.363 |
Goodwill, Net | 115.323 | 170.835 | 170.862 | 150.76 | 108.213 |
Intangibles, Net | 70.918 | 199.844 | 210.976 | 207.914 | 85.454 |
Other Long Term Assets, Total | 4.657 | 4.116 | 2.609 | 1.281 | 1.114 |
Total Current Liabilities | 102.082 | 73.92 | 72.22 | 40.003 | 75.728 |
Accounts Payable | 19.459 | 13.178 | 11.245 | 8.622 | 14.83 |
Accrued Expenses | 27.996 | 26.241 | 22.854 | 23.517 | 12.792 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 16.666 | 0.125 | 0.945 | |
Other Current Liabilities, Total | 54.627 | 34.501 | 21.455 | 7.739 | 47.161 |
Total Liabilities | 441.18 | 443.662 | 345.911 | 306.843 | 131.948 |
Total Long Term Debt | 320.634 | 348.799 | 249.285 | 226.294 | 45.152 |
Capital Lease Obligations | 0 | 0 | 0.003 | 0.152 | |
Deferred Income Tax | 1.38 | 1.402 | 3.354 | 8.656 | 0 |
Other Liabilities, Total | 17.084 | 19.541 | 21.052 | 31.89 | 11.068 |
Total Equity | -57.031 | 55.756 | 168.529 | 185.548 | 139.009 |
Redeemable Preferred Stock | |||||
Common Stock | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 354.214 | 320.392 | 352.445 | 288.345 | 209.33 |
Retained Earnings (Accumulated Deficit) | -407.857 | -260.347 | -179.9 | -98.934 | -66.498 |
Total Liabilities & Shareholders’ Equity | 384.149 | 499.418 | 514.44 | 492.391 | 270.957 |
Total Common Shares Outstanding | 27.1291 | 25.6664 | 24.0049 | 22.3213 | 20.5575 |
Note Receivable - Long Term | 3.35 | 0 | 1 | ||
Treasury Stock - Common | -3.391 | -4.292 | -4.018 | -3.865 | -3.825 |
Long Term Debt | 320.634 | 348.799 | 249.285 | 226.291 | 45 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total Current Assets | 146.681 | 142.953 | 170.26 | 179.844 | 266.304 |
Cash and Short Term Investments | 62.811 | 67.19 | 70.017 | 80.783 | 26.522 |
Cash | 62.811 | 67.19 | 70.017 | 80.783 | 26.522 |
Total Receivables, Net | 56.941 | 53.719 | 50.744 | 50.225 | 56.786 |
Accounts Receivable - Trade, Net | 36.999 | 35.786 | 34.367 | 34.032 | 42.367 |
Total Inventory | 8.659 | 7.39 | 6.566 | 5.735 | 5.798 |
Prepaid Expenses | 3.581 | 4.313 | 4.664 | 3.484 | 3.534 |
Other Current Assets, Total | 14.689 | 10.341 | 38.269 | 39.617 | 173.664 |
Total Assets | 355.937 | 355.597 | 384.149 | 403.846 | 484.468 |
Property/Plant/Equipment, Total - Net | 19.518 | 19.487 | 19.641 | 24.107 | 24.782 |
Property/Plant/Equipment, Total - Gross | 30.027 | 29.52 | 28.182 | 28.928 | 28.257 |
Accumulated Depreciation, Total | -20.658 | -20.112 | -19.024 | -18.89 | -18.131 |
Goodwill, Net | 115.323 | 115.323 | 115.323 | 115.323 | 115.323 |
Intangibles, Net | 68.206 | 69.159 | 70.918 | 72.881 | 73.245 |
Other Long Term Assets, Total | 6.209 | 6.125 | 4.657 | 4.691 | 4.814 |
Total Current Liabilities | 93.691 | 86.334 | 102.082 | 98.056 | 154.128 |
Accounts Payable | 20.623 | 21.906 | 19.459 | 14.685 | 15.802 |
Accrued Expenses | 25.772 | 19.6 | 27.996 | 23.108 | 20.213 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 57.2 | |||
Other Current Liabilities, Total | 47.296 | 44.828 | 54.627 | 60.263 | 60.913 |
Total Liabilities | 434.016 | 426.461 | 441.18 | 435.497 | 491.151 |
Total Long Term Debt | 321.312 | 320.972 | 320.634 | 320.297 | 319.963 |
Long Term Debt | 321.312 | 320.972 | 320.634 | 320.297 | 319.963 |
Deferred Income Tax | 1.507 | 1.492 | 1.38 | 0.889 | 1.034 |
Other Liabilities, Total | 17.506 | 17.663 | 17.084 | 16.255 | 16.026 |
Total Equity | -78.079 | -70.864 | -57.031 | -31.651 | -6.683 |
Common Stock | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
Additional Paid-In Capital | 359.573 | 356.901 | 354.214 | 349.911 | 335.756 |
Retained Earnings (Accumulated Deficit) | -433.606 | -423.755 | -407.857 | -378.215 | -338.15 |
Treasury Stock - Common | -4.049 | -4.013 | -3.391 | -3.35 | -4.292 |
Total Liabilities & Shareholders’ Equity | 355.937 | 355.597 | 384.149 | 403.846 | 484.468 |
Total Common Shares Outstanding | 27.0584 | 26.8685 | 27.1291 | 27.0814 | 26.2602 |
Capital Lease Obligations | |||||
Note Receivable - Long Term | 0 | 2.55 | 3.35 | 7 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -147.51 | -79.055 | -80.966 | -32.436 | -47.269 |
Cash From Operating Activities | 7.357 | 15.452 | 4.818 | -5.815 | 15.83 |
Cash From Operating Activities | 30.678 | 47.706 | 45.04 | 34.276 | 16.802 |
Deferred Taxes | -0.022 | 0.513 | -5.302 | -16.353 | -3.648 |
Non-Cash Items | 102.567 | 40.611 | 51.186 | 17.511 | 59.983 |
Cash Interest Paid | 7.204 | 8.678 | 5.808 | 3.181 | 0.72 |
Changes in Working Capital | 21.644 | 5.677 | -5.14 | -8.813 | -10.038 |
Cash From Investing Activities | 91.302 | -35.194 | -28.734 | -180.925 | -43.808 |
Capital Expenditures | -28.736 | -35.194 | -21.927 | -23.163 | -10.576 |
Other Investing Cash Flow Items, Total | 120.038 | 0 | -6.807 | -157.762 | -33.232 |
Cash From Financing Activities | -31.958 | 6.916 | 5.867 | 208.292 | 42.577 |
Financing Cash Flow Items | -2.531 | -0.11 | -8.02 | -140.352 | -2.029 |
Issuance (Retirement) of Stock, Net | 0.073 | 4.072 | 3.943 | 69.612 | 0.657 |
Issuance (Retirement) of Debt, Net | -29.5 | 2.954 | 9.944 | 279.032 | 43.949 |
Net Change in Cash | 66.701 | -12.826 | -18.049 | 21.552 | 14.599 |
Cash Taxes Paid | 0.123 | 0.053 | -0.024 | 0.381 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.898 | -147.51 | -117.868 | -77.803 | -28.193 |
Cash From Operating Activities | -8.754 | 7.357 | 9.753 | 8.84 | -15.735 |
Cash From Operating Activities | 6.2 | 30.678 | 24.285 | 18.562 | 13.073 |
Deferred Taxes | 0.112 | -0.022 | -0.513 | -0.368 | 0.276 |
Non-Cash Items | 8.551 | 102.567 | 83.734 | 56.696 | 13.884 |
Cash Taxes Paid | -0.028 | 0.123 | 0.137 | 0.137 | 0.008 |
Cash Interest Paid | 2.844 | 7.204 | 7.204 | 3.882 | 3.269 |
Changes in Working Capital | -7.719 | 21.644 | 20.115 | 11.753 | -14.775 |
Cash From Investing Activities | 0.18 | 91.302 | 93.68 | -18.341 | -8.966 |
Capital Expenditures | -3.204 | -28.736 | -24.881 | -18.341 | -8.966 |
Cash From Financing Activities | -0.403 | -31.958 | -30.898 | 27.41 | 27.41 |
Financing Cash Flow Items | -0.622 | -2.531 | -1.462 | -0.35 | -0.35 |
Issuance (Retirement) of Stock, Net | 0.219 | 0.073 | 0.064 | 0.06 | 0.06 |
Issuance (Retirement) of Debt, Net | 0 | -29.5 | -29.5 | 27.7 | 27.7 |
Net Change in Cash | -8.977 | 66.701 | 72.535 | 17.909 | 2.709 |
Other Investing Cash Flow Items, Total | 3.384 | 120.038 | 118.561 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Indaba Capital Management, L.P. | Hedge Fund | 24.1053 | 6521578 | 0 | 2023-09-21 | MED |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 4.2465 | 1148861 | 270175 | 2023-06-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 3.0726 | 831278 | 0 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.0556 | 826676 | 155225 | 2023-06-30 | LOW |
Knowlton (Calvin H.) | Individual Investor | 2.9993 | 811439 | 325000 | 2022-08-01 | |
Kent Lake Capital LLC | Hedge Fund | 2.2166 | 599691 | 599691 | 2023-06-30 | HIGH |
Apo Asset Management GmbH | Investment Advisor | 2.0644 | 558504 | -138746 | 2023-09-30 | MED |
Medical Strategy GmbH | Investment Advisor | 1.8112 | 490000 | 342000 | 2023-03-31 | MED |
Two Sigma Investments, LP | Hedge Fund | 1.7525 | 474140 | 224253 | 2023-06-30 | HIGH |
Knowlton (Orsula Voltis) | Individual Investor | 1.7391 | 470496 | 200000 | 2022-08-01 | |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.6456 | 445200 | 135553 | 2023-06-30 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.5917 | 430617 | 19297 | 2023-06-30 | LOW |
Adams (Brian W.) | Individual Investor | 1.5489 | 419047 | -55556 | 2023-09-21 | LOW |
Parametric Portfolio Associates LLC | Investment Advisor | 1.5091 | 408287 | 400826 | 2023-06-30 | LOW |
Kennedy Capital Management, Inc. | Investment Advisor | 1.3355 | 361323 | -455474 | 2023-06-30 | MED |
Invesco Capital Management LLC | Investment Advisor | 1.3134 | 355340 | 355340 | 2023-06-30 | LOW |
Fuller & Thaler Asset Management Inc. | Investment Advisor/Hedge Fund | 1.2939 | 350056 | -1590 | 2023-06-30 | LOW |
Repertoire Partners LP | Hedge Fund | 1.2927 | 349747 | -1407936 | 2023-06-30 | HIGH |
Greenhalgh (Michael) | Individual Investor | 1.1955 | 323442 | -41667 | 2023-09-21 | LOW |
EAM Investors, LLC | Investment Advisor/Hedge Fund | 0.9966 | 269632 | 269632 | 2023-06-30 | HIGH |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Tabula Rasa HealthCare Company profile
About Tabula Rasa HealthCare Inc
Tabula Rasa HealthCare, Inc. is a healthcare technology company. It operates through two segments: CareVention HealthCare and MedWise HealthCare. CareVention HealthCare segment provides Programs of All-Inclusive Care (PACE) programs to its clients, with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions and clinical pharmacist services at the point-of-care. MedWise HealthCare segment provides its clients, primarily health plans and retail pharmacies, with cloud-based software and clinical pharmacy programs. MedWise HealthCare clients include health plans, pharmacies and non-PACE healthcare providers. Services provided to these clients include medication safety services and software subscription solutions. It focuses on the medication safety market and creates solutions designed to enable pharmacists, providers and patients to optimize medication regimens. Its MedWise technology, identifies the cause of medication-related problems.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Tabula Rasa HealthCare Inc revenues increased 11% to $331.3M. Net loss decreased 2% to $79.1M. Revenues reflect CareVention HealthCare segment increase of 20% to $248M. Lower net loss reflects Interest Expense - Balancing value decrease of 56% to $9.1M (expense), Intangible asset Impairment charge decrease from $5M (expense) to $0K.
Industry: | Medical Software & Technology Services |
228 Strawbridge Drive
MOORESTOWN
NEW JERSEY 08057
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com